# Double Randomized and Placebo Controlled Trail of Sanchitongshu Combined Antiplatelet Drug to Prevent Ischemic Stroke

> **NCT04142151** · NA · UNKNOWN · sponsor: **Xinhua Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 60 (estimated)

## Conditions studied

- Ischemic Stroke
- Antiplatelet Effect

## Interventions

- **DRUG:** Sanchitongshu
- **DRUG:** Aspirin
- **DRUG:** Clopidogrel
- **DRUG:** placebo of Sanchitongshu

## Key facts

- **NCT ID:** NCT04142151
- **Lead sponsor:** Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04142151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04142151, "Double Randomized and Placebo Controlled Trail of Sanchitongshu Combined Antiplatelet Drug to Prevent Ischemic Stroke". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04142151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*